The impact of hypogammagammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation.
Ankersmit
H J
HJ
Hacker
S
S
Hoetzenecker
K
K
Moser
B
B
Wolner
E
E
D000361:Agammaglobulinemia / Q000150:complications* / Q000209:etiology; D000707:Anaphylaxis / Q000139:chemically induced; D017209:Apoptosis / Q000187:drug effects; D001402:B-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D051437:Renal Insufficiency / Q000139:chemically induced; D016896:Treatment Outcome
D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors